BeOne Medicines Ltd.
HealthcareNASDAQ:ONC · NASDAQ Global Market
+$4.21 today
Vol 0.26M · Avg 0.23M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $4.8B |
| Receivables | $948.4M |
| Inventory | $681.6M |
| Other Current | $179.7M |
| Total Current Assets | $6.6B |
| PP&E (Net) | $1.8B |
| Intangible Assets | $61.7M |
| Long-term Investments | $66.0M |
| Other Non-current | $36.0M |
| Total Non-current Assets | $2.0B |
| Total Assets | $8.6B |
Analysis
Selected assets total $8.6B for Latest. The largest visible component is Cash & Equivalents at $4.8B, about 56.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.5B +73.1% | $2.6B -17.2% | $3.2B -18.0% | $3.9B -11.6% | $4.4B | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 | $0 -100.0% | $2.6M -99.6% | $665.3M -70.3% | $2.2B | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $865.1M +22.0% | $709.1M +79.1% | $395.9M +99.0% | $199.0M -60.2% | $500.2M | $533.8M | $399.4M | -$1.7B |
| Inventory | $608.2M +22.9% | $495.0M +19.0% | $416.1M +47.4% | $282.3M +16.4% | $242.6M | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $212.8M +744.5% | $25.2M -55.2% | $56.3M +28600.5% | $196.0K -40.2% | $328.0K | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $6.2B +56.2% | $4.0B -5.0% | $4.2B -19.3% | $5.2B -31.6% | $7.6B | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $1.8B +8.0% | $1.7B +20.8% | $1.4B +48.5% | $924.0M +39.5% | $662.5M | $1.2B | $1.5B | $687.8M |
| Goodwill | $0 | $0 | $0 | $0 -100.0% | $109.0K | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $62.7M -51.7% | $129.8M +19.2% | $108.9M +15.1% | $94.6M -8.5% | $103.3M | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $82.5M -36.0% | $128.9M +43.8% | $89.6M -2.3% | $91.8M -8.9% | $100.8M | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 | $0 -100.0% | $110.4M | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $19.9M +48.8% | $13.4M -57.6% | $31.6M -49.0% | $61.9M +211.4% | -$55.5M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $2.0B +1.3% | $1.9B +20.4% | $1.6B +36.7% | $1.2B +27.2% | $921.6M | -$15.3B | $14.8B | $11.3B |
| Total Assets | $8.2B +38.3% | $5.9B +2.0% | $5.8B -9.0% | $6.4B -25.3% | $8.5B | $13.3B | $11.9B | $10.6B |
| Account Payables | $479.0M +18.3% | $405.0M +28.5% | $315.1M +6.9% | $294.8M +12.3% | $262.4M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $134.7M -84.2% | $851.5M +23.7% | $688.4M +109.2% | $329.0M -23.1% | $427.6M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $41.6M -31.6% | $60.8M +14.7% | $53.0M +20.5% | $44.0M -34.4% | $67.1M | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 | $0 | $0 -100.0% | $213.9M +14.1% | $187.4M | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $1.2B +238.0% | $359.5M +25.8% | $285.8M -4.4% | $299.1M +14.7% | $260.8M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $1.8B -17.4% | $2.2B +22.4% | $1.8B +23.3% | $1.5B -8.2% | $1.6B | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $1.8B +988.5% | $166.5M -15.8% | $197.6M -5.5% | $209.1M +3.5% | $202.1M | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $97.2M +131.4% | $42.0M +154.7% | $16.5M +3.1% | $16.0M +12.9% | $14.2M | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 -100.0% | $30.3M -11.3% | $34.2M -57.4% | $80.2M -69.9% | $266.6M | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $51.3M -43.5% | $90.7M -51.6% | $187.3M -0.1% | $187.5M -32.4% | $277.4M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $2.0B +438.7% | $373.8M -18.4% | $457.8M -13.2% | $527.4M -34.4% | $803.4M | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $3.8B +47.9% | $2.6B +14.1% | $2.3B +13.6% | $2.0B -16.9% | $2.4B | $14.7B | $3.7B | $9.6B |
| Common Stock | $144.0K +4.3% | $138.0K +2.2% | $135.0K +0.0% | $135.0K +1.5% | $133.0K | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$8.3B +3.3% | -$8.6B -8.1% | -$8.0B -12.5% | -$7.1B -39.5% | -$5.1B | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | -$78.2M +47.5% | -$149.0M -49.8% | -$99.4M -28.5% | -$77.4M -531.3% | $17.9M | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $4.4B +30.9% | $3.3B -5.8% | $3.5B -19.3% | $4.4B -28.5% | $6.1B | $9.1B | $7.7B | $3.3B |
| Total Debt | $2.0B +85.2% | $1.1B +16.1% | $930.2M +55.9% | $596.7M -14.1% | $694.6M | $724.2M | $410.6M | $399.4M |
| Net Debt | -$2.5B -64.6% | -$1.5B +31.0% | -$2.2B +31.5% | -$3.3B +11.1% | -$3.7B | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Humana Inc.
NYSE:HUM
$45.53B
Agilent Technologies, Inc.
NYSE:A
$36.67B
Alcon Inc.
NYSE:ALC
$32.58B
Natera, Inc.
NASDAQ:NTRA
$30.37B
IQVIA Holdings Inc.
NYSE:IQV
$30.29B
GE HealthCare Technologies Inc.
NASDAQ:GEHC
$29.65B
ResMed Inc.
NYSE:RMD
$28.25B
Koninklijke Philips N.V.
NYSE:PHG
$25.70B
Mettler-Toledo International Inc.
NYSE:MTD
$22.86B
Insmed Incorporated
NASDAQ:INSM
$21.21B
SEC Filings
Recent regulatory filings
No filings found.
How much cash does ONC have?
BeOne Medicines Ltd. (ONC) reported $4.55B in cash and equivalents in fiscal 2025.
How much debt does ONC carry?
BeOne Medicines Ltd. (ONC) reported $2.00B of total debt, with net debt of -$2,547,721,472.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.